The nuclear transcription factor κB (NF-κB);Le facteur de transcription nucleaire κB (NF-κB)

Revue de Medecine Interne

Volumn 19, Issue 12, 1998, Pages 945-947

  Mercie P ^a   Seigneur, M ^a   Bilhou Nabera, C ^a   Boisseau, M R ^a   Bernard, P ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Endothelial cell adhesion molecules; Inflammation; Transcription factors

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; AUTOREGULATION; B LYMPHOCYTE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENE TRANSLOCATION; REGULATOR GENE; SIGNAL TRANSDUCTION; ENDOTHELIUM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; INFECTION; INFLAMMATION; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ENDOTHELIUM; GENE EXPRESSION REGULATION; HUMANS; INFECTION; INFLAMMATION; NF-KAPPA B; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 0032293451     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)80074-5     Document Type: Article

References (13)

1. 1 Sen R, Baltimore D. Inducibility of k immunoglobulin enhancer-binding protein NF-κB by a post transcriptionnal mechanism. Cell 1986 ; 47 : 921-8
2. 2 Zabel U, Schreck R, Bauerle PA. DNA binding of purified trancription factor NF-κB. J Biol Chem 1991 ; 266 : 252-60
3. 3 Collins T, Read MA, Neish AS, Withley MZ, Thanos D, Maniatis T. Transcription of regulation of endothetial cell adhesion molecules: NF-κB and cytokines-inducible enhancers. FASEB J 1995 ; 9 : 899-909
4. 4 Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996 ; 14 : 649-83
5. 5 Beg AA, Baldwin AS. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 1993 ; 7 : 2064-70
6. 6 May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today 1998 ; 19 : 80-8
7. 7 Traenckner EBM, WiIk S, Bauerle PA. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBa that is still bound to NF-κB. EMBO J 1994 ; 13 : 5433-41
8. 8 Didonato J, Mercurio F, Rosette C. Mapping of the inducible IKκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 1996 ; 16 : 1295-304
9. 9 Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol Today 1997 ; 18 : 231-40
10. 10 Peyrade F, Taillan B, Lebrun C, Baron V, Dujardin P. Tyrosine kinase : implications en pathologie tumorale et perspectives thérapeutiques. Rev Méd Interne 1998 ; 19 : 366-72
11. 11 Barnes PJ, Karin M. Nuclear factor-κB. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997 ; 336 : 1066-71
12. 12 Mannig AM, Bell FP, Rosenbloom CL, Chosay JG, Simmons CA, Northrup JL et al. NF-κB is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. J Inflammation 1995 ; 45 : 283-96
13. 13 Foulds S. Novel flow cytometric method for quantifying nuclear binding of the transcription factor NF-κB in unseparated human monocytes and polymorphonuclear cells. Cytometry 1997 ; 29 : 182-6